Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (166)	6/6/2007 3:00:43 AM
From: tuck	Read Replies (2) \| Respond to of 285

The cardiovascular and renal drugs advisory committee meeting scheduled for August has been cancelled. So with an October PDUFA date and no meeting before then, it looks as though the vernakalant decision will be done without a committee. This perhaps derisks it a bit? I might have to start my position again, even though I think the overall market is ripe for some fairly serious consolidation. Somebody remind me, when are we expecting those oral vernakalant results? Edit: Never mind; oral 1235 results in Q4, yes? So I've got some time to re-enter, I'd think. Cheers, Tuck